trending Market Intelligence /marketintelligence/en/news-insights/trending/xN10wAzZMMNMYNem6ycFcg2 content esgSubNav
In This List

Lotus Bio-Technology Development fiscal Q3 loss narrows YOY

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix

Blog

Using ESG Analysis to Support a Sustainable Future


Lotus Bio-Technology Development fiscal Q3 loss narrows YOY

Lotus Bio-Technology Development Corp. said its normalized net income for the fiscal third quarter ended Dec. 31, 2015, amounted to a loss of $4,080, compared with a loss of $8,100 in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

Reported net income came to a loss of $6,530, or a loss of 0 cents per share, compared to a loss of $12,960, or a loss of 0 cents per share, in the year-earlier period.